Copyright
©2010 Baishideng Publishing Group Co.
World J Gastroenterol. Aug 28, 2010; 16(32): 4003-4012
Published online Aug 28, 2010. doi: 10.3748/wjg.v16.i32.4003
Published online Aug 28, 2010. doi: 10.3748/wjg.v16.i32.4003
Figure 1 Lymphangiogenic growth factors and their receptors expressed by lymphatic endothelium.
Vascular endothelial growth factor (VEGF) receptor (VEGFR)-3 is a member of the fms-like tyrosine kinase family and specifically binds VEGF-C and VEGF-D, but not VEGF-A. Recent studies also indicate an important role for the VEGF-A/VEGFR-2 signaling pathway in lymphangiogenesis.
Figure 2 Limitations of lymphatic vessel density estimations.
The central section of a tumor with a necrotic central core may estimate a misleadingly low lymphatic vessel density (LVD) (left), while the peripheral section of the same tumor may estimate a misleadingly high LVD (right).
- Citation: Nagahashi M, Ramachandran S, Rashid OM, Takabe K. Lymphangiogenesis: A new player in cancer progression. World J Gastroenterol 2010; 16(32): 4003-4012
- URL: https://www.wjgnet.com/1007-9327/full/v16/i32/4003.htm
- DOI: https://dx.doi.org/10.3748/wjg.v16.i32.4003